Continuous peritoneal perfusion: Techniques, methods and applications

Peritoneal Carcinomatosis: A Multidisciplinary Approach

Volumn , Issue , 2007, Pages 265-273

  Dahlke, Marc H ^a   Schlitt, Hans J ^a   Piso, Pompiliu ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

HUMAN; HYPERTHERMIC THERAPY; INFUSION; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PERITONEUM; REGIONAL PERFUSION; REVIEW;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; NEOPLASMS; PERITONEUM;

EID: 84892804354     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-48993-3_16     Document Type: Chapter

References (15)

1. Elias D, Antoun S, Goharin A et al. (2000) Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig 1:431-439
2. Elias D, Matsuhisa T, Sideris L, G. Liberale, L. Drouard-Troalen, B. Raynard, et al. (2004) Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tisssue distribution and tolerance. Ann Oncol 15:1558-1565
3. Glehen O, Osinksy D, Cotte E et al. (2003) Intraperitoneal chemothyperthermia using a closed abdominal procedure for the treatment of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:853-869
4. Gonzalez Bayon L, Gonzalez Moreno S, Ortega Perez G. (2006) Safety considerations for operating room personnel during hyperthermic intraperitoneal chemotherapy perfusion. Eur J Surg Oncol 32(6):619-624
5. Mohamed F, Marchettini P, Stuart OA, Yoo D, Sugarbaker PH. (2003) A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal delivery. Eur J Surg Oncol 29:261-265
6. Shido A, Ohmura S, Yamamoto K et al. (2000) Does hyperthermia induce peritoneal damage in continous hyperthermic peritoneal perfusion? World J Surg 24:507-511
7. Sticca RP, Dach BW. (2003) Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. Surg Oncol Clin N Am 12:689-701
8. Stephens AD, Alderman R, Chang D et al. (1999) Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 6:790-796
9. Stuart OA, Stephens AD, Welch L, Sugarbaker PH. (2002) Safety monitoring of the Coliseum technique for heated intraoperative intraperitoneal chemotherapy with Mitomycin C. Ann Surg Oncol 9:186-191
10. Sugarbaker PH, Averbach AM, Jaquet P et al. (1996) A simplified approach of hyperthermic intraoperative intraperitoneal chemotherapy using a self-sis: retaining retractor. In: Sugarbaker PH, editor, "Peritoneal carcinomato-Principles of management" Boston: Kluwer, p414-421
11. Sugarbaker PH. (2005) An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Oncol 2005,92:142-146
12. Sugarbaker PH, Mora JT, Carmignani P, Stuart OA, Yoo D. (2005) Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy. Oncologist 10:112-122
13. Sugarbaker PH, Stuart OA, Yoo D. (2005) Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy. J Oncol Pharm Practice 11:111-119
14. Sugarbaker PH, Stuart OA, Carmignani PC. (2006) Pharmakokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mytomycin C. Cancer Chemother Pharmacol 57:703-708
15. Sugarbaker PH, Clarke L. (2006) The approval process for hyperthermic intraoperative intraperitoneal chemotherapy. Eur J Surg Oncol 32(6):637-643